Skip to main content
An official website of the United States government

Government Funding Lapse

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit  cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at OPM.gov.

SHIP Trial - About the Study

The Self-collection for HPV testing to Improve Cervical Cancer Prevention (SHIP) Trial is a research study being conducted to help researchers determine the if self-collected vaginal samples for HPV testing provides similarly accurate results as cervical sample collected by a doctor.

If the SHIP Trial finds that human papillomavirus (HPV) testing from self-collected vaginal samples is as accurate as samples collected by clinician, self-collection methods may help cervical cancer screening rates by giving people more flexibility and comfort having the ability to collect samples themselves, compared to a doctor performing a speculum examination and collecting the samples in a clinic. The ultimate goal of SHIP is to increase the number of women screened for HPV and cervical cancer and prevent cervical cancer.

At home self-collected sampling is promising but has not been approved by the Food and Drug Administration (FDA) for cervical cancer testing in the US. The results from the NCI SHIP Study will help the FDA determine if this self-collected sample method can be approved for use at home. The self-collection devices being used in the SHIP Trial are under review by the FDA.